Kala制药(KALA)

2.97 -0.38 -11.3433%

今开:2.8565昨收:3.35
最高:3.01 最低:2.75
涨停价:0.0跌停价:0.0
总市值:1.91987824E8

Kala制药的热门评论

Kala制药(KALA)2020-05-01 23:30

$Kala制药(KALA)$ CT ORDER Confidential treatment order Accession Number: 9999999997-20-002358 Act: 33 Size: 124 KB 网页链接查看全文

Kala制药(KALA)2020-04-29 21:00

$Kala制药(KALA)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-20-004558 Act: 34 Size: 1 MB 网页链接查看全文

Kala制药(KALA)2020-04-29 21:05

$Kala制药(KALA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-20-004560 Act: 34 Size: 346 KB 网页链接查看全文

Kala制药(KALA)2020-03-16 20:10

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-003675 Size: 6 KB 网页链接查看全文

群氓鄙陋2019-02-22 21:07

$Kala制药(KALA)$ 这二十来天涨的也挺厉害的 @淘沙见金 有跟踪研究吗?谢谢查看全文

钟爱懿声2019-01-10 03:09

$Kala制药(KALA)$ 但凡小药厂产品开卖,大家都不看好,难道只有坐等被人收购的命?查看全文

Kala制药(KALA)2020-01-04 05:20

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-000157 Size: 5 KB 网页链接查看全文

群氓鄙陋2018-11-29 00:13

$Kala制药(KALA)$ 大股东曾经8.25左右增持200万股,难道打水漂了不成?查看全文

美股医药Z博士2018-10-08 22:24

$Kala Pharmaceuticals, Inc.(KALA)$ 公司主打眼科领域,干眼症药物3期结果虽然喜忧参半,但FDA同意开展另一个三期。同时另一款手术后消炎用激素类药物8月份获批。公司刚刚完成一轮增发,账面现金充足,市值仅2亿左右。上周五传出大股东增持2000万,利好。股价基本已经是ALL TIME LOW。建议买入长...查看全文

八千里路云和月2018-10-16 22:17

$Kala Pharmaceuticals, Inc.(KALA)$ 补了前期跳空的缺口,强势。查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的最新评论

当期报告

Kala制药(KALA)08-05 19:06

$Kala制药(KALA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-010375 Act: 34 Size: 385 KB 网页链接查看全文

Takeabreak07-26 21:10

$Kala制药(KALA)$ Symphony Health sales and volume estimates are as follows: For the week ending July 16, 2021: INVELTYS: Approximately $828k (MBS Dollars) in sales and 2,985 pack units (both up +20.7% week-over-week) -About 74% were from new prescriptions and 26% from refill...查看全文

Takeabreak07-22 11:50

$Karyopharm(KPTI)$ $G1治疗(GTHX)$ $Kala制药(KALA)$ BTAI. Value destroyers?? Commercialization is more risky. Lesson learned??? Or patience is a virtue ??查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

Kala制药(KALA)07-01 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-29,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,5548普通股, $5.56查看全文

持股变动声明

Kala制药(KALA)07-01 05:36

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003271 Size: 5 KB 网页链接查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF EXECUTIVE OFFICER,Iwicki Mark T ,卖出,7586普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF FINANCIAL OFFICER,Reumuth Mary ,卖出,2452普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,SEE REMARKS,Trachtenberg Eric ,卖出,2452普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,2452普通股, $5.77查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的公告

当期报告

$Kala制药(KALA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-010375 Act: 34 Size: 385 KB 网页链接

$Kala制药(KALA)$ 内部交易: 2021-06-29,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,5548普通股, $5.56

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003271 Size: 5 KB 网页链接

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF EXECUTIVE OFFICER,Iwicki Mark T ,卖出,7586普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF FINANCIAL OFFICER,Reumuth Mary ,卖出,2452普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,SEE REMARKS,Trachtenberg Eric ,卖出,2452普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF MEDICAL OFFICER,Brazzell Romulus K ,卖出,3034普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,2452普通股, $5.77

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003256 Size: 4 KB 网页链接

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003257 Size: 5 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24